Prospective study of follow up alone in stage I teratoma of the testis.
dc.contributor.author | Read, Graham R | |
dc.contributor.author | Johnson, Richard J | |
dc.contributor.author | Wilkinson, Peter M | |
dc.contributor.author | Eddleston, Brian | |
dc.date.accessioned | 2014-12-09T12:09:35Z | |
dc.date.available | 2014-12-09T12:09:35Z | |
dc.date.issued | 1983-11-19 | |
dc.identifier.citation | Prospective study of follow up alone in stage I teratoma of the testis. 1983, 287 (6404):1503-5 Br Med J (Clin Res Ed) | en |
dc.identifier.issn | 0267-0623 | |
dc.identifier.pmid | 6196076 | |
dc.identifier.uri | http://hdl.handle.net/10541/336953 | |
dc.description.abstract | In a prospective surveillance study of 45 patients with stage I teratoma of the testis 34 (76%) required no further treatment. Eleven patients relapsed but were salvaged by chemotherapy and radiotherapy. Seven patients relapsed within three months of the initial assessment and only one after more than 12 months. These preliminary results suggest that a follow up policy in stage I teratoma of the testis is possible but only in a regional centre with facilities for close monitoring of patients. | |
dc.language.iso | en | en |
dc.rights | Archived with thanks to British medical journal (Clinical research ed.) | en |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols | |
dc.subject.mesh | Bleomycin | |
dc.subject.mesh | Castration | |
dc.subject.mesh | Cisplatin | |
dc.subject.mesh | Etoposide | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Lung Neoplasms | |
dc.subject.mesh | Male | |
dc.subject.mesh | Prednisolone | |
dc.subject.mesh | Prospective Studies | |
dc.subject.mesh | Teratoma | |
dc.subject.mesh | Testicular Neoplasms | |
dc.subject.mesh | Vinblastine | |
dc.subject.mesh | Vindesine | |
dc.title | Prospective study of follow up alone in stage I teratoma of the testis. | en |
dc.type | Article | en |
dc.contributor.department | Christie Hospital and Holt Radium Institute, Manchester M20 9BX | en |
dc.identifier.journal | British Medical Journal | en |
html.description.abstract | In a prospective surveillance study of 45 patients with stage I teratoma of the testis 34 (76%) required no further treatment. Eleven patients relapsed but were salvaged by chemotherapy and radiotherapy. Seven patients relapsed within three months of the initial assessment and only one after more than 12 months. These preliminary results suggest that a follow up policy in stage I teratoma of the testis is possible but only in a regional centre with facilities for close monitoring of patients. |